
Number of publications published per year by Wege, Henning. (Source : PubMed)

Distribution of publications types for Wege, Henning. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Aurora kinase inhibitor PHA-739358 suppresses growth of hepatocellular carcinoma in vitro and in a xenograft mouse model.
Neoplasia
2009;11;9

Hepatic stem and progenitor cells in liver diseases and hepatocarcinogenesis.
Minerva Gastroenterol Dietol
2009;55;2
Absence of oncogenic transformation despite acquisition of cytogenetic aberrations in long-term cultured telomerase-immortalized human fetal hepatocytes.
Cancer Lett.
2007;256;1
Regeneration in pig livers by compensatory hyperplasia induces high levels of telomerase activity.
Comp Hepatol
2007;6
Differentiation of human and mouse embryonic stem cells along a hepatocyte lineage.
Cell Transplant
2004;13;3

Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential.
Gastroenterology
2003;124;2
In vitro expansion of human hepatocytes is restricted by telomere-dependent replicative aging.
Cell Transplant
2003;12;8
[ See timeline ] [ See all publications ]
means that Wege, Henning has 7 papers cited a least 7 times - methodology
Transplant Research Institute, University of California, Davis Medical Center, Sacramento, CA 95817, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.